Sulfated Chitosan Derivatives Block Viral Entry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for viral infections, particularly those caused by SARS-CoV-2 and RSV, are limited in effectiveness and often associated with significant side effects, highlighting the need for alternative therapeutic agents that can inhibit viral entry into host cells.
Innovation Solution
Development of sulfated chitosan derivatives that mimic the structure of heparan sulfates, allowing them to bind to viral proteins and prevent their interaction with cellular receptors, thereby blocking viral entry into host cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for viral infections are used, then viral infections can be treated, but treatment effectiveness is limited and significant side effects occur
Solution Approach 1:
The sulfated chitosan derivatives act as intermediary molecules that bind to viral proteins (such as SARS-CoV-2 spike protein) and prevent their interaction with cellular receptors (ACE2). This mediator approach blocks viral entry without requiring the virus to overcome existing drug resistance mechanisms, thereby improving treatment effectiveness while avoiding the side effects associated with conventional antivirals like ribavirin
2Reliability
If sulfated chitosan derivatives are used to block viral entry, then viral entry rates are reduced, but the mechanism must overcome viral attachment to heparan sulfates
Solution Approach 1:
The sulfated chitosan derivatives are designed to copy the structural features of natural heparan sulfates, which are naturally occurring glycosaminoglycans that viruses normally bind to for cell attachment. By creating synthetic copies with similar sulfated polysaccharide structures, the derivatives can competitively bind to viral attachment proteins and block viral entry, achieving high antiviral activity through structural mimicry rather than complex molecular mechanisms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sulfated chitosan derivatives demonstrate significant antiviral activity by reducing viral entry rates, as evidenced by reduced luminescence and fluorescence signals in cell culture assays, indicating a protective effect against SARS-CoV-2 and RSV infections.
Implementation Method 1
The sulfated chitosan derivatives demonstrate significant antiviral activity by reducing viral entry rates
Data Source
AI summary
The invention relates to sulfated chitosan derivatives of formula (I), wherein the meanings for the various substituents are as disclosed in the description, for their use in the treatment and/or prevention of a viral infection, particularly wherein the viral infection is caused by SARS-CoV-2 such as COVID-19 or RSV.